NASDAQ:CTMX

Cytomx Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy CTMX

*Your capital is at risk

$3.16

-0.290 (-8.41%)

At Close: Jun 02, 2026

Currently predicting for Thu, 4 Jun 2026

CTMX Prediction Chart

CTMX Predictions History

Latest community submissions for CTMX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
thedean2010 Merchant	Aug 9, 2024	Bullish	$1.20	V	—	1
Skagitqg Merchant	Jan 13, 2023	Bearish	$2.86	X	—	0
Andrew Cheung @AndrewCheung.174392	Mar 22, 2021	Bullish	$8.52	X	—	1
JS Pro	May 1, 2020	$10.05 -10.35%	$11.21	X	89.65%	0
Telemachos Chatzitheodorou @TelemachosChatzitheodorou.139675	May 1, 2020	$30.00 +167.62% Unrealistic Excluded from avg	$11.21	X	0.00%	1
NameNotImportant Pro	May 6, 2019	$10.06 -3.18%	$10.39	X	96.82%	0
BB.DEES..100571	Feb 27, 2019	$20.00 +57.11%	$12.73	X	42.90%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CTMX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CYTOMX THERAPEUTICS

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by